Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MYM Nutraceuticals Inc MYMMF

Healthcare Drug Manufacturers - Major
MYM Nutraceuticals Inc is a Canada based company engaged in the business of acquiring and developing natural remedies. The company is focused on the medical marijuana business by producing cannabis growing facilities and products.


GREY:MYMMF - Post by User

MYM Nutraceuticals Inc
Bullboard Posts
User Avatar Image
(5)
•••
Comment by Stockguy01on Nov 21, 2018 6:34pm
132 Views
Post# 29007412

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Weedon

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:WeedonHaving dealt with the regulatory sectors in both Provincial and Federal forums for years, I have never seen an application go through on the original submittal with any regulator. This is a learning curve for all involved, especially with this being a new sector. There are always non- compliance to the standard that have to be met and usually very fixable once the interpretation of the requirements are understood.  I’m sure there are staffing issues on the regulator end too. 


Having said all this it’s been a long time and the reflection is in the stock price. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities